Navigation Links
Effect Of Cooling And Exercise To Be Analyzed In Patients With Multiple Sclerosis

Multiple sclerosis is a form of autoimmune disorder that occurs in individuals who produce antibodies against their own cells or tissues. In multiple sclerosis, the antibodies are directed towards the fatty sheaths around nerve cells. //

Fatigue is the most common symptom of the disease. It can be to a certain extent by aerobic exercise. One of the limitations in this regard is that MS appears to cause the body to heat up more quickly, leading to a compromise on the exercise potential.

A new study targeted towards providing a better quality of life for these patents will investigate if cooling the body before or during exercise would allow for longer hours of exercise. The study also will determine the effects of a 12-week aerobic exercise program on fitness, core and skin temperature, and heat flux in MS patients.

Exercise can build up strength and endurance, reduce depression and increase endorphins, the chemicals in the brain responsible for positive moods. This should however be done correctly to reap the maximum beneficial effect.

The study would be conducted in two phases on a group of 60 persons with the disease. During the first phase, which will comprise four weeks, each participant will exercise under a different cooling condition each week (no cooling; cooling before exercise by wearing a specially designed, temperature-controlled cooling vest; cooling during exercise while wearing the vest, and cooling using a method of their choosing other than the vest) to determine how different cooling methods affect exercise performance and core body temperature.

The patients will also swallow a temperature pill developed by the NASA that would transmit the temperature reading to an external monitor during its travel through the human body.

Various physiological measurements that will help enable the identification of the effect and effectiveness of the cooling measures adopted. It is hoped that the coolin
'"/>




Page: 1 2

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Inhaled Steroids Safe & Effective for Children with Asthma
3. Acupuncture May Help Chemotherapy Side Effects
4. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
5. Fluoride Found Effective in Osteoporosis
6. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
7. Implantable Contact Lens Found Safe and Effective
8. Effective And Economical Agent For Anthrax
9. Stem Cell Transplants May Be Effective For MS Patients
10. Chemotherapy Pill Has Fewer Side Effects Than IV
11. Effect of Osteosarcoma predicted by scans

Post Your Comments:
(Date:12/2/2009)...tailing plastic surgery procedures is now availabl...dates can view procedures and print out informatio... (PRWEB) December 2, 2009 -- Recovery..., has always been dedicated to providing resources...es, providing liposuction garments, breast augment...
(Date:12/2/2009)...chieves IBM Ready for LINUX designation and enhanc...mainframe and contemporary systems running Linux. ...ember 2, 2009 -- eCube Systems, a leader in legacy...nounced that it has achieved the IBM Ready for LIN...dleware. This mark certifies NXTera has met compa...
(Date:12/2/2009)...-- A randomized, controlled study comparing standa...eatment called percutaneous disc decompression for...reatments help patients in the short run, only dis...years later. Results of the study, the first of it... of the Radiological Society of North America (RSN...
(Date:12/2/2009)... comparing standard conservative therapy to a mini...decompression for painful herniated disc revealed ...ort run, only disc decompression kept patients pai..., the first of its kind, were presented today at t...orth America (RSNA). , Discs are sponge-like cus...
(Date:12/1/2009)...swire/ -- Reportlinker.com announces that a new ma...: ,, The Future of Central Nervous System Dise...etitive Benchmarking, Product Pipeline and Deals A...14/The-Future-of-Central-Nervous-System-Diseases-T...-Benchmarking-Product-Pipeline-and-Deals-Analysis....
Breaking Medicine News(10 mins):Health News:Online Compression Garments Retailer Introduces 3D Animation of Surgical Procedures 2Health News:eCube Delivers Linux on System z Support for NXTera High Performance Middleware 2Health News:eCube Delivers Linux on System z Support for NXTera High Performance Middleware 3Health News:Outpatient Disc Treatment Gives Long-Term Back Pain Relief 2Health News:Outpatient Disc Treatment Gives Long-Term Back Pain Relief 3Health News:Outpatient disc treatment gives long-term back pain relief 2Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 13Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 14Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 15Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 16Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 17Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 18Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 19Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 20Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 21Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 22
... Johnson &,Johnson will participate in the Eleven...ence on Tuesday, March 18th at the Loews Miami Bea...resident, Finance and Chief,Financial Officer, wil...,by accessing the Johnson & Johnson website at ht...
... Liu, CEO and Founder of,Ingenious Med and a pract...ntly appointed to serve on the Benchmarks Committe...Liu and the rest of the Benchmarks Committee,will ...arks for hospitalists nationwide in the areas of h...
...athon(R) is pleased to,announce a new Small Child ...der volume instrument with patent-pending NeuralHa...ealth care providers to measure,bladder volume non...ced BladderScan(R) BVI 9400 will make its official...
...rsity of Maryland study of whether people receive ...r race or ethnicity found that when whites and min...ason, they receive the same quality care in that h...ch 11 issue of Health Affairs. The study of 1841 h...
...ral candidate at Georgetown University, has been n...nor Society (Bouchet Society). Crawford is in the...ve Cancer Center, part of the Georgetown Universit...76). The Society aims to recognize outstanding sc...
...or Disease Control has awarded the Indiana Univers...ract with the possibility of nearly $10 million in...ability of local, state and regional entities to s... emergencies. , The funding will allow researcher...
Other Medicine News:Health News:Dr. Steve Liu, CEO of Ingenious Med, Joins Benchmarks Committee at SHM 2Health News:Verathon Inc. Launches Enhanced BladderScan(R) Bladder Volume Instrument With Small Child Mode 2Health News:Verathon Inc. Launches Enhanced BladderScan(R) Bladder Volume Instrument With Small Child Mode 3Health News:Minorities, whites get equal care in hospitals 2Health News:Georgetown U student selected for prestigious Bouchet Society 2Health News:Regenstrief Institute tapped by CDC to combat potentially catastrophic disease outbreaks 2
(Date:12/1/2009)... Wash., Dec. 1 SCOLR Pha...ember 20, 2009 it licensed to Chrono Nutraceutical...d sell four extended release dietary supplements u...latform. In addition, SCOLR granted Chrono rights...he United States on a nonexclusive basis. Chrono ...
(Date:12/1/2009)..., Dec. 1 CEL-SCI Corpora...pany and a developer of vaccines and therapeutics ...eases, announced today that it has retained the se...ization (CRO) to run CEL-SCI,s upcoming Phase III ...ancer with the Company,s lead product candidate, M...
(Date:12/1/2009)...LLE, N.C., Dec. 1 nContact Surgica...n of devices for minimally-invasive treatment for ...f a feasibility clinical trial designed to evaluat...nd catheter procedure, the convergent procedure, f...fibrillation (AF). This prospective, feasibility ...
Breaking Medicine Technology:SCOLR Pharma, Inc. Licenses Dietary Supplements 2SCOLR Pharma, Inc. Licenses Dietary Supplements 3CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine 2CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine 3nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure 2Eli Lilly and Company Opens Eco Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation 5848 1Eli Lilly and Company Opens Eco Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation 5848 2Eli Lilly and Company Opens Eco Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation 5848 3Eli Lilly and Company Opens Eco Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation 5848 4Eli Lilly and Company Opens Eco Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation 5848 5Patent Attorneys McDaniel and Stipkala to Confer at Summit November 4 2009 60349 1House Healthcare Bill 3A Government Run Plan Other Key Provisions Undermine Goals of Access and Affordability 60346 1House Healthcare Bill 3A Government Run Plan Other Key Provisions Undermine Goals of Access and Affordability 60346 2House Healthcare Bill 3A Government Run Plan Other Key Provisions Undermine Goals of Access and Affordability 60346 3
...ggest Clinically Meaningful Primary Endpoint for C...tional World Muscle Society,Congress -, SOUTH PLA...TC) today announced promising findings in patients... at the 13th International World Muscle Society,(W...assessing the utility,of the 6-minute walk test (6...
...ent inhibitor to be tested in AMD patients, LOUIS...privately held biotechnology company developing me...egeneration (AMD) announced today that the,Company...positive safety,results in its Phase I study. POT-...complement activation cascade that could otherwise...
Other Medicine Technology:PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy 2PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy 3PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy 4PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy 5Potentia Pharmaceuticals Announces Positive Safety Data and Study Expansion in Phase I Trial for Lead Drug Candidate POT-4 2
...c has been a key participant in the area of blood ...us Medtronic autotransfusion systems allowed clini...latelets, as well as to determine requirements for...ch plasma (PRP) for a small amount of autologous b...
RX HERCULINK® PLUS Biliary Stent System
Response Catheter
Fast-Cath™ Guiding Introducers
Medicine Products: